Internal Medicine
Online ISSN : 1349-7235
Print ISSN : 0918-2918
ISSN-L : 0918-2918
45 巻, 5 号
選択された号の論文の33件中1~33を表示しています
EDITORIALS
REVIEW ARTICLE
  • Kiwamu Okita
    2006 年 45 巻 5 号 p. 229-233
    発行日: 2006年
    公開日: 2006/04/03
    ジャーナル オープンアクセス
    HCC in Japan has very different characteristics from that in other Asian countries. Because, among the Japanese HCC patients approximately 80% of the patients are HCV positive and they are aged over 60 years old. On the other hand, in many Asian countries HBVpositive HCC patients are dominant and their age is younger than the Japanese patients.
    Early diagnosis of HCC is mainly performed by means of imaging diagnostic technique such as abdominal ultrasonography, dynamic CT, dynamic MRI and CT angiography. If small HCC less than 3 cm in diameter is found and liver function is well preserved, local ablation therapy or surgical treatment promises better than 5 years survival (over 60%). While, TAE or TACE is performed in cases of HCC larger than 3 cm in size, if liver failure is not complicated. In advanced HCC cases with multiple tumors, arterial infusion of anticancer drug has been applied. However, its efficacy is not estimated.
    Chemoprevention is another modality for HCC. Eradication of HCV with an antiviral agent has proven to prevent hepatocarcinogenesis. As for chemoprevention of HCC, some trials are on going in Japan.
ORIGINAL ARTICLES
  • Hiroki Satoh, Tetsuo Nishino, Kazuo Tomita, Yasuaki Saijo, Reiko Kishi ...
    2006 年 45 巻 5 号 p. 235-239
    発行日: 2006年
    公開日: 2006/04/03
    ジャーナル オープンアクセス
    Objective: The objective of this study was to elucidate the relationship between risk factors and the coronary artery disease (CAD) in young middleaged Japanese men.
    Methods: A cohort study of 2,764 young middleaged Japanese men aged 3544 (mean±SD: 42.3±2.5) years based on a 10year followup to identify the risk factors for the occurrence of CAD was conducted. There were 35 cases of CAD during the follow up; 25 myocardial infarctions and 10 angina pectoris. The Cox Proportional hazard model was used to identify the independent risk factors for CAD. Adjustment was made for variables including age, body mass index, smoking habit, systolic blood pressure, total cholesterol (TC), highdensity lipoprotein cholesterol (HDLC), fasting plasma glucose (FPG), and triglyceride.
    Results: TC, low HDLC, and FPG were identified as significant independent risk factors for CAD. Adjusted hazard ratio (HR) of a high level of TC≥220 (mg/dl) for CAD was 5.46 (95% confidence interval (CI): 1.9617.51) and that of a high level of HDLC<50(mg/dl) was 9.01 (95%CI: 1.1372.17), and a high level of FPG≥110 (mg/dl) was 2.94 (95%CI: 1.228.23). Considering the combination of these risk factors, adjusted HR for CAD of the subjects who had 2 risk factors was 8.37 (95%CI: 2.2131.65).
    Conclusions: Using the database of young middleaged Japanese men, TC, low HDLC, and FPG were found to be important risk factors for CAD, and the combination of these risk factors was associated with CAD.
  • Haruki Musha, Akio Hayashi, Keisuke Kida, Eiji Takahashi, Kae Suzuki, ...
    2006 年 45 巻 5 号 p. 241-245
    発行日: 2006年
    公開日: 2006/04/03
    ジャーナル オープンアクセス
    Objective: Highdensity lipoprotein cholesterol (HDLC) levels are known to be reduced in the metabolic syndrome, but the HDLC profile of elderly patients with coronary artery disease (CAD) has not been well characterized. This study investigated the gender difference of HDLC levels in elderly Japanese patients with CAD.
    Methods: Serum lipid data were analyzed retrospectively to assess sexrelated differences of the lipid profile, and to evaluate the effects of pharmacotherapy or physical exercise on hyperlipidemia.
    Patients: A total of 163 elderly (≥65 years) outpatients with CAD (128 men aged 70.6±5.2 years and 35 women aged 74.1±6.0 years [mean±SD]) were investigated.
    Results: The mean total cholesterol (TC), lowdensity lipoprotein cholesterol (LDLC), and triglyceride (TG) levels were similar in men and women, while the mean HDLC level was significantly higher in women than men (58.3±18.1 vs. 50.3±13.5 mg/dL; p=0.0064). The HDLC level was not significantly influenced by oral lipidlowering therapy or regular exercise in either sex. However, women without lipidlowering therapy had significantly higher HDLC levels than men with (p=0.0312) or without (p=0.0338) lipidlowering therapy, while women performing regular exercise had significantly higher HDLC levels than men with (p=0.0047) or without (p<0.001) regular exercise.
    Conclusion: Elderly women with CAD have higher HDLC levels relative to their postmenopausal state than those of men with CAD. Low HDLC levels, unlike in men, may not be a major risk factor for CAD in elderly women.
  • Naoto Tomita, Fumio Kodama, Shigeki Motomura, Hideyuki Koharazawa, Hir ...
    2006 年 45 巻 5 号 p. 247-252
    発行日: 2006年
    公開日: 2006/04/03
    ジャーナル オープンアクセス
    Objective: The International Prognostic Index (IPI) was reported in 1993 and it is now widely used for predicting the outcome in patients with aggressive nonHodgkin's lymphoma. It defines 5 risk factors and 4 distinct risk groups from retrospective data. In this study, we evaluated the outcome of riskadopted therapy for diffuse large Bcell lymphoma (DLBCL), the most common aggressive lymphoma, and assessed the possible prognostic factors.
    Methods and Patients: We treated 177 consecutive patients newly diagnosed with DLBCL using therapies determined by putative risk factors. Therapies included CHOP followed by involved field irradiation; ACOMPB with the consolidation regimen MLY9; highdose chemotherapy supported by autologous peripheral blood stem cell transplantation; or performance status (PS) oriented CHOP. Statistical analysis was performed to determine the comprehensive risk factors in DLBCL.
    Results: Overall, the complete response (CR), 3year overall survival (OS), and 3year relapsefree survival (RFS) rates for CR patients were 71%, 69%, and 75%, respectively. Male gender, high LDH, poor PS (≥2), more than one extranodal involvement site, and B symptoms were independent adverse prognostic factors for OS. High LDH and poor PS were independent, adverse prognostic factors for RFS.
    Conclusion: In the 5 risk factors indicated by IPI, high LDH and poor PS remained for OS and RFS even after riskadopted therapy.
  • Yuichiro Inatomi, Tomohiro Takita, Toshiro Yonehara, Shodo Fujioka, Yo ...
    2006 年 45 巻 5 号 p. 253-257
    発行日: 2006年
    公開日: 2006/04/03
    ジャーナル オープンアクセス
    Objective: We investigated the efficacy of edaravone in patients with cardioembolic stroke.
    Methods: Cardioembolic stroke patients were treated with drip intravenous infusion of edaravone (ED group, n=141) for 7 days, and were retrospectively compared with a historicalcontrolled cohort of similar patients (control group, n=114).
    Results: Early improvement (between day 0 and day 10), defined as change in National Institutes of Health Stroke Scale (NIHSS), was seen more frequently in mild patients (NIHSS on admission ≤7) among the ED group than in the control group (change in NIHSS +2 vs. -2, respectively, p=0.013). Similar efficacy was not seen in the moderate to severe (NIHSS >7) patients. Independent patients (modified Rankin Scale ≤2) 6 months after the onset were likely to be less frequent in the ED than the control group (28% versus 41%; p=0.066). Other clinical outcomes in the ED group were not significantly different from those in the control group.
    Conclusion: The results suggest that edaravone may only be effective in mild patients with cardioembolic stroke.
  • Masamitsu Yanada, Hitoshi Kiyoi, Makoto Murata, Momoko Suzuki, Masanor ...
    2006 年 45 巻 5 号 p. 259-264
    発行日: 2006年
    公開日: 2006/04/03
    ジャーナル オープンアクセス
    Objective: Invasive fungal infection is a major cause of morbidity and mortality in patients with febrile neutropenia unresponsive to antibacterial treatment. Empirical antifungal therapy with amphotericin B has been the standard of care for these patients; however, there remains a need for less toxic alternative drugs.
    Patients and Methods: We conducted a prospective study to evaluate the efficacy and safety of micafungin (MCFG), a novel antifungal agent of the echinocandin class, in an empirical therapy setting for patients with febrile neutropenia.
    Results: A total of 31 patients with acute leukemia who developed febrile neutropenia were enrolled in the study. Among them, 18 patients fulfilling the protocoldefined criteria, including 10 with persistent fever and 8 with recurrent fever, received MCFG empirically. Underlying diseases consisted of acute myeloid leukemia (n=15) and acute lymphoblastic leukemia (n=3). The median duration of neutropenia and drug administration was 22 and 9.5 days, respectively. Treatment success, defined as defervescence during the neutropenic period, absence of breakthrough fungal infections, and requiring no replacement of antifungal drugs, was achieved in 14 patients (78%). None of the patients required discontinuation or dose reduction due to adverse events except for one patient with severe hypokalemia.
    Conclusions: Although the studied patients were limited in number, our results indicate that MCFG is an encouraging agent for empirical antifungal therapy in patients with febrile neutropenia, and deserves further investigation in largescale studies.
CASE REPORTS
SHORT COMMUNICATION
PICTURES IN CLINICAL MEDICINES
LETTERS TO THE EDITORS
feedback
Top